2000
DOI: 10.1099/0022-1317-49-1-5
|View full text |Cite
|
Sign up to set email alerts
|

Tropical and exotic infections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0
1

Year Published

2001
2001
2013
2013

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 200 publications
(176 reference statements)
0
3
0
1
Order By: Relevance
“…Secondly, B. pseudomallei is resistant to diverse groups of antimicrobials including third generation cephalosporins whilst quinolones and aminoglycosides have no reliable effect [8,9]. Hence, a definitive and rapid diagnosis is critical and vital prior to the administration of ceftazidime or carbapenems as these antibiotics are generally not used as empirical treatment for septicaemia in endemic regions.…”
Section: Introductionmentioning
confidence: 99%
“…Secondly, B. pseudomallei is resistant to diverse groups of antimicrobials including third generation cephalosporins whilst quinolones and aminoglycosides have no reliable effect [8,9]. Hence, a definitive and rapid diagnosis is critical and vital prior to the administration of ceftazidime or carbapenems as these antibiotics are generally not used as empirical treatment for septicaemia in endemic regions.…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3][4] Similarly, the causative agent of a less severe variety of enteric fever, S. enterica serotype Paratyphi A, has also been reported to have developed resistance to multiple antibiotics. 5 Epidemiological studies using the pulsed field gel electrophoresis (PFGE) technique have established that multidrug-resistant S. enterica serotype Typhi isolates circulating in Asia are not derived from a single clone. 6 Enteric fever is endemic in Nepal.…”
Section: Introductionmentioning
confidence: 99%
“…Due to the severity of acute infection, B. pseudomallei is classified as an Advisory Committee on Dangerous Pathogens category 3 pathogen and category B bioterrorism agent. Currently, no vaccine against the organism exists, and antibiotic treatment is complicated by the fact that B. pseudomallei is intrinsically resistant to many antibiotics including aminoglycosides and the early ␤-lactams (4). A number of virulence determinants including flagella (10), a capsular polysaccharideencoding region (33), and an Inv/Mxi-Spa-like type III secretion system involved in the intracellular behavior of the pathogen (38,39) have been identified in this organism.…”
mentioning
confidence: 99%